시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 척추후측만증 치료 시장 보고서(2025년)
Kyphoscoliosis Treatment Global Market Report 2025
상품코드 : 1691995
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 200 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,496,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,390,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,284,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

척추후측만증 치료 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년에는 5.8%의 CAGR로 41억 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 개인화된 치료 접근법, 생체역학 연구의 확대, 원격 모니터링 및 원격의료 서비스, 지속적인 유전자 연구에 기인합니다. 예측 기간 동안 주요 동향으로는 첨단 수술 기술, 혁신적인 보조기 기술, 맞춤형 치료 계획, 3D 프린팅의 채택, 통증 관리의 혁신 등이 있습니다.

척수 손상의 증가는 척추후측만증 치료 시장의 성장을 촉진할 것으로 예상됩니다. 척추 손상은 척추, 추간판, 인대, 근육, 신경, 기타 지지 구조를 포함한 척추의 구성요소에 대한 모든 손상, 외상, 위해를 말합니다. 척수 손상으로 인한 척추후측만증 치료에는 정형외과적 평가, 물리치료, 보조기, 수술 가능성, 통증 관리, 환자 교육 및 개인별 맞춤 치료 계획에 중점을 둔 다학제적 의료팀 등 종합적인 접근이 필요합니다. 예를 들어, 미국 앨라배마 주정부 기관인 앨라배마 주 공중보건국에 따르면, 2022년 2월 ATR은 2021년 4,734건 대비 2022년 3,817건의 머리와 척수를 포함한 신경학적인 손상을 보고했습니다. 그 결과, 척수 손상의 증가는 척추후측만증 치료 시장의 성장을 촉진하고 있습니다.

원격의료 이용의 증가는 척추후측만증 치료 시장의 성장을 더욱 촉진할 것으로 예상됩니다. 원격의료란 화상 회의, 전화, 디지털 메시징 등의 통신 기술을 통해 원격지에서 제공되는 의료 서비스를 말합니다. 이를 통해 환자는 의료기관에 직접 방문하지 않고도 정형외과 전문의나 척추외과 전문의와 상담할 수 있어 특히 신체적 어려움을 겪고 있는 척추후만증 환자에게 도움이 됩니다. 예를 들어, 미국에 본사를 둔 비영리 단체인 록헬스(Rock Health)는 2023년 2월, 조사 응답자의 80%가 2021년 72%에서 2022년 어느 시점에 원격의료를 이용했다고 보고했습니다. 이처럼 원격의료의 이용 증가는 헬스케어 운송 서비스 시장의 성장에 기여하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

ksm
영문 목차

영문목차

Kyphoscoliosis is a spinal condition characterized by abnormal forward curvature (kyphosis) and sideways curvature (scoliosis) of the spine, leading to postural and respiratory problems. The treatment involves medical interventions and therapies aimed at managing and correcting the spinal deformity, improving posture, reducing pain, and preventing further spinal curvature.

The main types of kyphoscoliosis include postural kyphosis, Scheuermann's kyphosis, congenital kyphosis, and kyphoscoliosis. Postural kyphosis refers to the rounding or hunching of the back, typically affecting teenagers and young adults. Treatment options for kyphoscoliosis encompass medications, surgery, and bracing, and these are implemented by hospitals, clinics, and ambulatory surgical centers.

The kyphoscoliosis treatment market research report is one of a series of new reports from The Business Research Company that provides kyphoscoliosis treatment market statistics, including kyphoscoliosis treatment industry global market size, regional shares, competitors with a kyphoscoliosis treatment market share, detailed kyphoscoliosis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the kyphoscoliosis treatment industry. This kyphoscoliosis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The kyphoscoliosis treatment market size has grown strongly in recent years. It will grow from $3.08 billion in 2024 to $3.27 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to exploration of regenerative medicine, genetic research contributions, telemedicine and remote monitoring, advancements in rehabilitation programs.

The kyphoscoliosis treatment market size is expected to see strong growth in the next few years. It will grow to $4.1 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to personalized treatment approaches, expansion of biomechanical research, remote monitoring and telehealth services, continued genetic research. Major trends in the forecast period include advanced surgical techniques, innovative bracing technologies, customized treatment plans, adoption of 3D printing, pain management innovations.

The growing number of spinal cord injuries is anticipated to drive the expansion of the kyphoscoliosis treatment market. Spinal cord injuries refer to any damage, trauma, or harm to the spine's components, including the vertebrae, intervertebral discs, ligaments, muscles, nerves, and other supportive structures, which can lead to the development of kyphoscoliosis and alterations in spinal alignment. Treating kyphoscoliosis caused by spinal cord injuries involves a holistic approach, including orthopedic evaluation, physical therapy, bracing, possible surgery, pain management, and a multidisciplinary healthcare team focused on patient education and personalized care plans. For example, in February 2022, according to the Alabama Department of Public Health, a US-based state agency, the ATR reported 3,817 neurological injuries involving the head and spinal cord in 2022, compared to 4,734 cases in 2021. As a result, the increasing number of spinal cord injuries is fueling the growth of the kyphoscoliosis treatment market.

The rise in telemedicine usage is expected to further drive the growth of the kyphoscoliosis treatment market. Telemedicine refers to healthcare services delivered remotely through telecommunications technologies, such as videoconferencing, phone calls, and digital messaging. It enables patients to consult with orthopedic specialists and spine surgeons without needing to travel to healthcare facilities, which is particularly beneficial for individuals with kyphoscoliosis who may face physical challenges. For example, in February 2023, Rock Health, a US-based non-profit, reported that 80% of survey respondents had used telemedicine at some point in 2022, up from 72% in 2021. Thus, the increased use of telemedicine is contributing to the growth of the healthcare transportation service market.

The increasing incidence of genetic disorders is expected to be a significant catalyst for the growth of the kyphoscoliosis treatment market. Genetic disorders, stemming from abnormalities or mutations in an individual's DNA, often involve spinal curvature abnormalities requiring kyphoscoliosis treatment. The prevalence of genetic conditions in children is estimated to be 1 in 25 in the UK, affecting over 2.4 million individuals. The multidisciplinary treatment approach, encompassing various strategies such as beta-blocker therapy, physical therapy, and orthopedic surgeon supervision, underlines the pivotal role of kyphoscoliosis treatment in managing genetic disorders and contributes to market growth.

Leading companies in the kyphoscoliosis treatment market are developing innovative products, such as the MARVEL Growing Rod System, specifically designed for early-onset scoliosis. The MARVEL Growing Rod System is a posterior stabilizing rod that can be surgically implanted and periodically lengthened through hand-operated mechanical actuation. For example, in July 2023, Globus Medical Inc., a US-based medical device company, launched the MARVEL Growing Rod System. It is designed to assist patients under 10 years old with early-onset scoliosis in achieving and maintaining spinal correction while allowing for continued growth through minimally invasive distraction. The system offers significant distraction, immediate tactile feedback, and automated locking, ensuring reliable growth. This innovative product, the Growing Rod System, is expected to contribute to the future growth of the market.

Major companies operating in the kyphoscoliosis treatment market report are Johnson & Johnson Services Inc., Aspen Medical Products LLC, Medtronic PLC, Stryker Corporation, Milwaukee Brace Company, Zimmer Biomet Holdings Inc., Perrigo Company PLC, Teva Pharmaceuticals Inc., B. Braun Melsungen Aktiengesellschaft, Aurobindo Pharma Limited, Integra LifeSciences Ltd., NuVasive Inc., DJO Global Inc., Globus Medical Inc., Boston Orthotics & Prosthetics, Ossur hf., Aesculap Inc., DeRoyal Industries Inc., MicroPort Scientific Corp., Alphatec Holdings Inc., Trulife Ltd., Ottobock SE & Co. KGaA, Orthofix Holdings Inc., OrthoPediatrics Corp., Proteor S.A., Orthomerica Products Inc., Breg Inc., Innomed Inc., Restorative Care of America Inc., Spinal Elements Inc.

North America was the largest region in the kyphoscoliosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kyphoscoliosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the kyphoscoliosis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The kyphoscoliosis treatment market consists of revenues earned by entities by providing services such as physical therapy, pain management, specialist psychological support, and medical evaluation. The market value includes the value of related goods sold by the service provider or included within the service offering. The kyphoscoliosis treatment market also includes sales of lumbar support cushions, orthopedic braces, back support belts, and exercise and therapy equipment. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Kyphoscoliosis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on kyphoscoliosis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for kyphoscoliosis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The kyphoscoliosis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Kyphoscoliosis Treatment Market Characteristics

3. Kyphoscoliosis Treatment Market Trends And Strategies

4. Kyphoscoliosis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Kyphoscoliosis Treatment Growth Analysis And Strategic Analysis Framework

6. Kyphoscoliosis Treatment Market Segmentation

7. Kyphoscoliosis Treatment Market Regional And Country Analysis

8. Asia-Pacific Kyphoscoliosis Treatment Market

9. China Kyphoscoliosis Treatment Market

10. India Kyphoscoliosis Treatment Market

11. Japan Kyphoscoliosis Treatment Market

12. Australia Kyphoscoliosis Treatment Market

13. Indonesia Kyphoscoliosis Treatment Market

14. South Korea Kyphoscoliosis Treatment Market

15. Western Europe Kyphoscoliosis Treatment Market

16. UK Kyphoscoliosis Treatment Market

17. Germany Kyphoscoliosis Treatment Market

18. France Kyphoscoliosis Treatment Market

19. Italy Kyphoscoliosis Treatment Market

20. Spain Kyphoscoliosis Treatment Market

21. Eastern Europe Kyphoscoliosis Treatment Market

22. Russia Kyphoscoliosis Treatment Market

23. North America Kyphoscoliosis Treatment Market

24. USA Kyphoscoliosis Treatment Market

25. Canada Kyphoscoliosis Treatment Market

26. South America Kyphoscoliosis Treatment Market

27. Brazil Kyphoscoliosis Treatment Market

28. Middle East Kyphoscoliosis Treatment Market

29. Africa Kyphoscoliosis Treatment Market

30. Kyphoscoliosis Treatment Market Competitive Landscape And Company Profiles

31. Kyphoscoliosis Treatment Market Other Major And Innovative Companies

32. Global Kyphoscoliosis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Kyphoscoliosis Treatment Market

34. Recent Developments In The Kyphoscoliosis Treatment Market

35. Kyphoscoliosis Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기